Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia. [NA]

View source ↗

Summary

A study evaluating ET-01 transplantation for transfusion-dependent beta-thalassemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• ET-01

Snippet

Sponsor: EdiGene (GuangZhou) Inc. | Conditions: Transfusion Dependent Beta-Thalassaemia | NA | Status: TERMINATED